Aerie Pharmaceutical (NASDAQ:AERI).
Adage Capital Partners Gp, L.l.c. reports that it sold 375,000 shares last quarter decreasing its holdings in Aerie Pharmaceutical by 10.9%. Its investment was valued at $149,445,000 a decrease of $31,853,000 according to the filing.
Several firms have updated their holdings. As of quarter end Schwab Charles Investment Management Inc had acquired 14,379 shares growing its holdings by 10.4%. The value of the investment in AERI increased from $7,268,000 to $7,420,000 a change of 2.1% quarter to quarter. Sectoral Asset Management Inc divested its ownership by selling 29,278 shares a decrease of 7.3%. Sectoral Asset Management Inc controls 373,396 shares valued at $18,147,000. The value of the position overall is down by 14.2%.
Partner Fund Management, L.p. grew its investment by buying 665,421 shares an increase of 38.1% in the quarter. Partner Fund Management, L.p. claims 2,413,461 shares worth $117,294,000. The total value of its holdings increased 27.7%.
On November 9 Mizuho kept the stock rating at “Buy” targeting a price of $87.00. November 3 investment analysts at Mizuho reiterated a “Buy” rating on the company.
October 25 investment analysts at Mizuho maintained a company rating of “Buy” with a current price target of $70.00. Equity analyst Guggenheim released research on AERI with an initial rating of “Buy”.
October 16 investment analysts at Mizuho made no change to the stock rating of “Buy” projecting a price of $70.00. On October 16 Needham & Company LLC held the company rating at “Buy” targeting a price of $76.00.
The company is so far trading down by 0.17% since yesterday’s close of 59.3. The P/E ratio is N/A and market capitalization is 2.17B. In the last earnings report the EPS was $-3.35 with 36.70M shares presently outstanding.
Traders are a little more bullish on the company looking at the fall in short interest. The company experienced a fall in short interest of -11.90% as of October 13, 2017 from the last reporting period. Short shares fell 538,812 over that timeframe. With short interest at 3,987,552 and short average daily volume at 1,300,215, days to cover is 3.0 and the percentage of shorted shares was 0.11% on October 13.